{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T02:59:48Z","timestamp":1769137188345,"version":"3.49.0"},"reference-count":141,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.dld.2025.11.025","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T12:32:31Z","timestamp":1766233951000},"page":"171-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The immunological profile of children with portal hypertension"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9915-8972","authenticated-orcid":false,"given":"Fabiola","family":"Di Dato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7483-234X","authenticated-orcid":false,"given":"Raffaele","family":"Iorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-4855","authenticated-orcid":false,"given":"Eirini","family":"Kyrana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0174-4787","authenticated-orcid":false,"given":"Tassos","family":"Grammatikopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.dld.2025.11.025_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-017-9827-9","article-title":"The portal hypertension syndrome: etiology, classification, relevance, and animal models","volume":"12","author":"Bosch","year":"2018","journal-title":"Hepatol Int"},{"issue":"2","key":"10.1016\/j.dld.2025.11.025_bib0002","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/archdischild-2015-310022","article-title":"Portal hypertension and its management in children","volume":"103","author":"Grammatikopoulos","year":"2018","journal-title":"Arch Dis Child"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0003","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/HEP.0000000000000844","article-title":"AASLD practice Guideline on noninvasive liver disease assessment of portal hypertension","volume":"81","author":"Sterling","year":"2025","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0004","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u20132021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0005","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII \u2013 Renewing consensus in portal hypertension","volume":"76","author":"De Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0006","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jum.14764","article-title":"Diagnostic performance of ultrasound elastography for evaluating portal hypertension in children: a systematic review and meta-analysis","volume":"38","author":"Kim","year":"2019","journal-title":"J Ultrasound Med"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0007","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.23.30506","article-title":"MR and ultrasound elastography for fibrosis assessment in children: practical implementation and supporting evidence\u2014 AJR Expert Panel narrative Review","volume":"223","author":"Serai","year":"2024","journal-title":"Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0008","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/jpn3.70115","article-title":"Variability in the management of portal hypertension across European countries: a survey-study by ESPGHAN Portal Hypertension Special Interest Group","volume":"81","author":"Roilidis","year":"2025","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"10.1016\/j.dld.2025.11.025_bib0009","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/archdischild-2020-319600","article-title":"Evolving management of paediatric portal hypertension","volume":"106","author":"Luoto","year":"2021","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/MPG.0000000000001882","article-title":"Non-invasive markers of portal hypertension: appraisal of adult experience and potential utilisation in children","volume":"66","author":"Sutton","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2025.11.025_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.649668","article-title":"Divergences in macrophage activation markers soluble CD163 and mannose receptor in patients with non-cirrhotic and cirrhotic portal hypertension","volume":"12","author":"\u00d8rntoft","year":"2021","journal-title":"Front Physiol"},{"issue":"9","key":"10.1016\/j.dld.2025.11.025_bib0012","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/hep4.1560","article-title":"Natural course of pediatric portal hypertension","volume":"4","author":"Kassam","year":"2020","journal-title":"Hepatol Commun"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0013","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/MPG.0b013e31826eb0cf","article-title":"Portal hypertension in children and young adults with biliary atresia","volume":"55","author":"Shneider","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0014","first-page":"170","article-title":"The long-term outcome of the Kasai operation in patients with biliary atresia: a systematic review","volume":"71","author":"Bijl","year":"2013","journal-title":"Neth J Med"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/S0004-28032012000100012","article-title":"Portal vein thrombosis in children and adolescents: 20 years experience of a pediatric hepatology reference center","volume":"49","author":"Ferri","year":"2012","journal-title":"Arq Gastroenterol"},{"issue":"8","key":"10.1016\/j.dld.2025.11.025_bib0016","first-page":"1179","article-title":"Etiology, presenting features and outcome of children with non-cirrhotic portal vein thrombosis: a multicentre national study","volume":"51","author":"Di Giorgio","year":"2019","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"issue":"2","key":"10.1016\/j.dld.2025.11.025_bib0017","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/children9020297","article-title":"Rex Shunt for extra-hepatic portal venous obstruction in children","volume":"9","author":"Zhang","year":"2022","journal-title":"Children"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0018","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/hep.28153","article-title":"Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: summary of the Baveno VI Pediatric Satellite Symposium","volume":"63","author":"Shneider","year":"2016","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.dld.2025.11.025_bib0019","doi-asserted-by":"crossref","first-page":"658","DOI":"10.3390\/cells8070658","article-title":"The lymphatic headmaster of the mast cell-related splanchnic inflammation in portal hypertension","volume":"8","author":"Aller","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.dld.2025.11.025_bib0020","article-title":"Portal hypertension as immune mediate disease","volume":"14","author":"Manti","year":"2014","journal-title":"Hepat Mon"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0021","article-title":"Current clinical evidence on the effect of general anesthesia on neurodevelopment in children: an updated systematic review with meta-regression","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0022","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ANA.0000000000000118","article-title":"Review: effects of anesthetics on brain circuit formation","volume":"26","author":"Wagner","year":"2014","journal-title":"J Neurosurg Anesthesiol"},{"issue":"8","key":"10.1016\/j.dld.2025.11.025_bib0023","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.ejrad.2015.04.021","article-title":"Assessment of surgical portosystemic shunts and associated complications: the diagnostic and therapeutic role of radiologists","volume":"84","author":"Taslakian","year":"2015","journal-title":"Eur J Radiol"},{"issue":"7","key":"10.1016\/j.dld.2025.11.025_bib0024","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201745","article-title":"GIMAP5 maintains liver endothelial cell homeostasis and prevents portal hypertension","volume":"218","author":"Drzewiecki","year":"2021","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.dld.2025.11.025_bib0025","first-page":"1079","article-title":"Portal hypertension: from pathophysiology to clinical practice","volume":"25","author":"Laleman","year":"2005","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.dld.2025.11.025_bib0026","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1479-5876-5-44","article-title":"The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension","volume":"5","author":"Aller","year":"2007","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.dld.2025.11.025_bib0027","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1478-3231.2011.02579.x","article-title":"Endothelial dysfunction in the regulation of cirrhosis and portal hypertension","volume":"32","author":"Iwakiri","year":"2012","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.dld.2025.11.025_bib0028","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MPG.0000000000002932","article-title":"Unusual clinical course for untreated malformative biliary atresia infant: is portal hypertension an important driver of liver fibrosis?","volume":"72","author":"Di Dato","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"23\u201324","key":"10.1016\/j.dld.2025.11.025_bib0029","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00508-009-1288-2","article-title":"Innate immune dysfunction in acute and chronic liver disease","volume":"121","author":"Leber","year":"2009","journal-title":"Wien Klin Wochenschr"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0030","first-page":"700","article-title":"Implications and management of cirrhosis-associated immune dysfunction before and after liver transplantation","volume":"28","author":"Tranah","year":"2022","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"issue":"2","key":"10.1016\/j.dld.2025.11.025_bib0031","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MPG.0000000000000578","article-title":"Duodenal morphometry and small bowel permeability in children with portal hypertension","volume":"60","author":"Borkar","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.dld.2025.11.025_bib0032","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/nu16071025","article-title":"Gut-liver axis dysregulation in portal hypertension: emerging frontiers","volume":"16","author":"Lombardi","year":"2024","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.dld.2025.11.025_bib0033","article-title":"Role of gut-derived endotoxins in porto-sinusoidal vascular disorder: comparison between patients with and without portal hypertension","volume":"45","author":"Overi","year":"2025","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0034","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12876-024-03483-6","article-title":"The effect of propranolol on gastrointestinal motility and permeability in patients with cirrhosis and significant portal hypertension","volume":"24","author":"Xirouchakis","year":"2024","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0035","first-page":"510","article-title":"Influence of portal pressure change on intestinal permeability in patients with portal hypertension","volume":"1","author":"Xu","year":"2002","journal-title":"Hepatobiliary Pancreat Dis Int HBPD INT"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0036","first-page":"1392","article-title":"Postoperative portal hypertension enhances alloimmune responses after living-donor liver transplantation in patients and in a mouse model","volume":"203","author":"Hashimoto","year":"2019","journal-title":"J Immunol Baltim Md 1950"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0037","article-title":"Cystic fibrosis liver disease in children - A review of our current understanding","volume":"121","author":"Costaguta","year":"2023","journal-title":"Arch Argent Pediatr"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0038","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jhep.2024.05.014","article-title":"Angiocrine signaling in sinusoidal homeostasis and liver diseases","volume":"81","author":"Gao","year":"2024","journal-title":"J Hepatol"},{"issue":"18","key":"10.1016\/j.dld.2025.11.025_bib0039","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.3390\/jcm13185582","article-title":"Liver cirrhosis: the immunocompromised State","volume":"13","author":"Rodr\u00edguez-Negrete","year":"2024","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0040","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1136\/gutjnl-2020-320786","article-title":"Targeting the gut-liver-immune axis to treat cirrhosis","volume":"70","author":"Tranah","year":"2021","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0041","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2013.01.005","article-title":"Macrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosis","volume":"58","author":"Waidmann","year":"2013","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.dld.2025.11.025_bib0042","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/gut.2010.234542","article-title":"Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS","volume":"60","author":"Holland-Fischer","year":"2011","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0043","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cyto.2005.04.008","article-title":"Portal hypertension produces an evolutive hepato-intestinal pro- and anti-inflammatory response in the rat","volume":"31","author":"Palma","year":"2005","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0044","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3748\/wjg.v10.i5.689","article-title":"Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension","volume":"10","author":"Wang","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0045","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1053\/gast.1996.v110.pm8608897","article-title":"Portal hypertension enhances endotoxin-induced intercellular adhesion molecule 1 up-regulation in the rat","volume":"110","author":"Pan\u00e9s","year":"1996","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.dld.2025.11.025_bib0046","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1046\/j.1440-1746.2000.2330.x","article-title":"Predominant T helper 1 cells in patients with idiopathic portal hypertension","volume":"15","author":"Tokushige","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.dld.2025.11.025_bib0047","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1007\/s10620-006-9596-0","article-title":"Clinical features, serum interleukin-6, and interferon-\u03b3 levels of 34 Turkish patients with hepatoportal sclerosis","volume":"52","author":"K\u00f6ksal","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0048","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1440-1746.1999.01857.x","article-title":"Analysis of adhesion molecules in patients with idiopathic portal hypertension","volume":"14","author":"Yamaguchi","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0049","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/hep.26755","article-title":"Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients","volume":"59","author":"Buck","year":"2014","journal-title":"Hepatol Baltim Md"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0050","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/hepr.14175","article-title":"Serum pro-inflammatory cytokine interleukin-6 level is predictive of further decompensation and mortality in liver cirrhosis","volume":"55","author":"Ikeda","year":"2025","journal-title":"Hepatol Res Off J Jpn Soc Hepatol"},{"key":"10.1016\/j.dld.2025.11.025_bib0051","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/9930902","article-title":"Comparison of inflammatory cytokine levels in hepatic and jugular veins of patients with cirrhosis","volume":"2023","author":"Kaps","year":"2023","journal-title":"Mediators Inflamm"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0052","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3892\/ijmm.2014.1662","article-title":"Effects of phased joint intervention on IL-35 and IL-17 expression levels in patients with portal hypertension","volume":"33","author":"Wang","year":"2014","journal-title":"Int J Mol Med"},{"issue":"11","key":"10.1016\/j.dld.2025.11.025_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143380","article-title":"Peripheral and hepatic vein cytokine levels in correlation with non-alcoholic fatty liver disease (NAFLD)-related metabolic, histological, and haemodynamic features","volume":"10","author":"Vonghia","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0054","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/vim.2017.0176","article-title":"Effect of splenectomy on serum cytokine profiles in Hepatitis B virus-related cirrhosis patients with portal hypertension","volume":"31","author":"Huang","year":"2018","journal-title":"Viral Immunol"},{"issue":"6","key":"10.1016\/j.dld.2025.11.025_bib0055","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1478-3231.2011.02504.x","article-title":"Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases: CXCR3 chemokines in liver diseases","volume":"31","author":"Tacke","year":"2011","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0056","article-title":"New insights on the role of vascular endothelial growth factor in biliary pathophysiology","volume":"3","author":"Mariotti","year":"2021","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0057","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000234823","article-title":"Alterations in function and subpopulations of peripheral blood mononuclear leukocytes in children with Portal hypertension leukocyte subtypes and function in Portal hypertension","volume":"88","author":"Ferrante","year":"1989","journal-title":"Int Arch Allergy Immunol"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0058","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1440-1746.1990.tb01440.x","article-title":"Characterization of peripheral blood lymphocytes in patients with non-cirrhotic portal fibrosis: a comparison with cirrhotics and healthy controls","volume":"5","author":"Nayyar","year":"1990","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0059","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1440-1746.1990.tb01421.x","article-title":"Immunological profile of patients with non-cirrhotic portal fibrosis","volume":"5","author":"Sarin","year":"1990","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0060","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/clin.1995.1073","article-title":"Abnormal T cell activation and skewed T cell receptor v\u03b2 repertoire usage in Japanese patients with idiopathic portal hypertension","volume":"75","author":"Tokushige","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0061","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/509580","article-title":"The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients","volume":"44","author":"McGovern","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0062","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0016-5085(80)90081-5","article-title":"Immune function in patients with extrahepatic portal venous obstruction and the effect of splenectomy","volume":"79","author":"Webb","year":"1980","journal-title":"Gastroenterology"},{"issue":"123","key":"10.1016\/j.dld.2025.11.025_bib0063","first-page":"581","article-title":"The expression and significance of CD4+CD25+CD127low\/- regulatory T cells and Foxp3 in patients with portal hypertension and hypersplenism","volume":"60","author":"Guo","year":"2013","journal-title":"Hepatogastroenterology"},{"issue":"15","key":"10.1016\/j.dld.2025.11.025_bib0064","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3748\/wjg.14.2377","article-title":"Changes in count and function of splenic lymphocytes from patients with portal hypertension","volume":"14","author":"Li","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.dld.2025.11.025_bib0065","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.humimm.2018.07.233","article-title":"The portal vein as a distinct immunological compartment \u2013 A comprehensive immune phenotyping study","volume":"79","author":"Queck","year":"2018","journal-title":"Hum Immunol"},{"key":"10.1016\/j.dld.2025.11.025_bib0066","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ebiom.2019.10.011","article-title":"CD8+ T cells from patients with cirrhosis display a phenotype that may contribute to cirrhosis-associated immune dysfunction","volume":"49","author":"Leboss\u00e9","year":"2019","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0067","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000534740","article-title":"COVID-19 vaccination in liver cirrhosis: safety and immune and clinical responses","volume":"31","author":"Canha","year":"2024","journal-title":"GE Port J Gastroenterol"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0068","first-page":"187","article-title":"Alves de Tommaso AM. Antibody titers and response to vaccination against hepatitis A and B in pediatric patients with portal hypertension","volume":"38","author":"Rosa MN de","year":"2008","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0069","first-page":"96","article-title":"Biliary atresia: indications and timing of liver transplantation and optimization of pretransplant care","volume":"23","author":"Sundaram","year":"2017","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.sempedsurg.2012.05.003","article-title":"Biliary atresia: cellular dynamics and immune dysregulation","volume":"21","author":"Feldman","year":"2012","journal-title":"Semin Pediatr Surg"},{"issue":"8","key":"10.1016\/j.dld.2025.11.025_bib0071","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jpedsurg.2015.02.005","article-title":"Th-17 cells infiltrate the liver in human biliary atresia and are related to surgical outcome","volume":"50","author":"Hill","year":"2015","journal-title":"J Pediatr Surg"},{"issue":"9346","key":"10.1016\/j.dld.2025.11.025_bib0072","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(02)11603-5","article-title":"Genetic induction of proinflammatory immunity in children with biliary atresia","volume":"360","author":"Bezerra","year":"2002","journal-title":"The Lancet"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0073","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jpedsurg.2006.01.060","article-title":"Increased CXCR3 expression associated with CD3-positive lymphocytes in the liver and biliary remnant in biliary atresia","volume":"41","author":"Shinkai","year":"2006","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0074","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1203\/01.PDR.0000130480.51066.FB","article-title":"Biliary atresia is associated with CD4+ Th1 cell\u2013Mediated portal tract inflammation","volume":"56","author":"Mack","year":"2004","journal-title":"Pediatr Res"},{"issue":"50","key":"10.1016\/j.dld.2025.11.025_bib0075","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028197","article-title":"ANKRD1 and SPP1 as diagnostic markers and correlated with immune infiltration in biliary atresia","volume":"100","author":"Kong","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.dld.2025.11.025_bib0076","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/imcb.12366","article-title":"CXCL8high inflammatory B cells in the peripheral blood of patients with biliary atresia are involved in disease progression","volume":"98","author":"Zhang","year":"2020","journal-title":"Immunol Cell Biol"},{"issue":"6","key":"10.1016\/j.dld.2025.11.025_bib0077","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/jgh.12900","article-title":"Interleukin-8: a critical chemokine in biliary atresia","volume":"30","author":"Dong","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2025.11.025_bib0078","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jpedsurg.2005.11.044","article-title":"Elevated expression of IL2 is associated with increased infiltration of CD8+ T cells in biliary atresia","volume":"41","author":"Shinkai","year":"2006","journal-title":"J Pediatr Surg"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0079","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2220\/biomedres.38.269","article-title":"CCL5 is induced by TLR 3 signaling in HuCCT1 human biliary epithelial cells: possible involvement in the pathogenesis of biliary atresia","volume":"38","author":"Shimada","year":"2017","journal-title":"Biomed Res"},{"issue":"2","key":"10.1016\/j.dld.2025.11.025_bib0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jclinpath-2012-201097","article-title":"Participation of natural killer cells in the pathogenesis of bile duct lesions in biliary atresia","volume":"66","author":"Okamura","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.dld.2025.11.025_bib0081","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fped.2019.00279","article-title":"CD4+T cell subset profiling in biliary atresia reveals ICOS\u2212 regulatory T cells as a favorable prognostic factor","volume":"7","author":"Zhang","year":"2019","journal-title":"Front Pediatr"},{"issue":"8","key":"10.1016\/j.dld.2025.11.025_bib0082","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jpedsurg.2005.05.007","article-title":"Immune-mediated liver injury: prognostic value of CD4+, CD8+, and CD68+ in infants with extrahepatic biliary atresia","volume":"40","author":"Kotb","year":"2005","journal-title":"J Pediatr Surg"},{"issue":"12","key":"10.1016\/j.dld.2025.11.025_bib0083","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00383-013-3421-6","article-title":"Elevated Th17 cells accompanied by decreased regulatory T cells and cytokine environment in infants with biliary atresia","volume":"29","author":"Yang","year":"2013","journal-title":"Pediatr Surg Int"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0084","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep4.1332","article-title":"Correlation of immune markers with outcomes in biliary atresia following intravenous immunoglobulin therapy","volume":"3","author":"Kim","year":"2019","journal-title":"Hepatol Commun"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0085","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s12519-015-0023-5","article-title":"The correlation between plasma cytokine levels in jaundice-free children with biliary atresia","volume":"11","author":"Jian","year":"2015","journal-title":"World J Pediatr"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0086","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/hep.21701","article-title":"Serial circulating markers of inflammation in biliary atresia\u2014Evolution of the post-operative inflammatory process","volume":"46","author":"Narayanaswamy","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.dld.2025.11.025_bib0087","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s12519-017-0018-5","article-title":"Expression of programmed death-1 and its ligands in the liver of biliary atresia","volume":"13","author":"Wang","year":"2017","journal-title":"World J Pediatr"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0088","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0973-6883(12)60078-4","article-title":"Comparison of circulating endothelial cell\/platelet count ratio to aspartate transaminase\/platelet ratio index for identifying patients with cirrhosis","volume":"2","author":"Sethi","year":"2012","journal-title":"J Clin Exp Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2025.11.025_bib0089","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1478-3231.2009.02132.x","article-title":"A prospective pilot study of circulating endothelial cells as a potential new biomarker in portal hypertension","volume":"30","author":"Abdelmoneim","year":"2010","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"6","key":"10.1016\/j.dld.2025.11.025_bib0090","article-title":"Increased sinusoidal pressure impairs liver endothelial mechanosensing, uncovering novel biomarkers of portal hypertension","volume":"5","author":"Ortega-Ribera","year":"2023","journal-title":"JHEP Rep Innov Hepatol"},{"issue":"11","key":"10.1016\/j.dld.2025.11.025_bib0091","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/jpsu.2001.27929","article-title":"Plasma endothelin-1 level as a marker reflecting the severity of portal hypertension in biliary atresia","volume":"36","author":"Hasegawa","year":"2001","journal-title":"J Pediatr Surg"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0092","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3748\/wjg.v10.i5.689","article-title":"Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension","volume":"10","author":"Wang","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.dld.2025.11.025_bib0093","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s003830050380","article-title":"Clinical significance of plasma endothelin levels in patients with biliary atresia","volume":"13","author":"Kobayashi","year":"1998","journal-title":"Pediatr Surg Int"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0094","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/he.2000.6596","article-title":"production and release of endothelin-1 from the gut and spleen in portal hypertension due to cirrhosis","volume":"31","author":"Nagasue","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2025.11.025_bib0095","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8341030","article-title":"Systemic and splanchnic lipopolysaccharide and endothelin-1 plasma levels in liver cirrhosis before and after transjugular intrahepatic portosystemic shunt","volume":"2016","author":"Meng","year":"2016","journal-title":"Gastroenterol Res Pract"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0096","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/jlts.2000.9735","article-title":"Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver","volume":"6","author":"Kamath","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.dld.2025.11.025_bib0097","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cyto.2015.12.023","article-title":"Significant hepatic expression of IL-2 and IL-8 in biliary atresia compared with other neonatal cholestatic disorders","volume":"79","author":"Arafa","year":"2016","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.dld.2025.11.025_bib0098","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.3390\/jcm10122705","article-title":"Prognostic and pathophysiologic significance of IL-8 (CXCL8) in biliary atresia","volume":"10","author":"Godbole","year":"2021","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.dld.2025.11.025_bib0099","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00383-004-1329-x","article-title":"Serum interleukin-8 in children with biliary atresia: relationship with disease stage and biochemical parameters","volume":"21","author":"Honsawek","year":"2005","journal-title":"Pediatr Surg Int"},{"issue":"7","key":"10.1016\/j.dld.2025.11.025_bib0100","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1053\/jpsu.2002.33840","article-title":"Levels of circulating antiinflammatory cytokine interleukin-1 receptor antagonist and proinflammatory cytokines at different stages of biliary atresia","volume":"37","author":"Kobayashi","year":"2002","journal-title":"J Pediatr Surg"},{"issue":"7","key":"10.1016\/j.dld.2025.11.025_bib0101","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jpedsurg.2007.09.007","article-title":"Evaluation of hepatocyte growth factor in patients with biliary atresia","volume":"43","author":"Hsieh","year":"2008","journal-title":"J Pediatr Surg"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0102","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/bjs5.50308","article-title":"Ki67 expression at Kasai portoenterostomy as a prognostic factor in patients with biliary atresia","volume":"4","author":"Yoshii","year":"2020","journal-title":"BJS Open"},{"issue":"04","key":"10.1016\/j.dld.2025.11.025_bib0103","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-0029-1216378","article-title":"Elevated serum bone morphogenetic protein 7 levels and clinical outcome in children with biliary atresia","volume":"19","author":"Chayanupatkul","year":"2009","journal-title":"Eur J Pediatr Surg"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0104","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.surg.2018.12.003","article-title":"Divergent expression of liver transforming growth factor superfamily cytokines after successful portoenterostomy in biliary atresia","volume":"165","author":"Kerola","year":"2019","journal-title":"Surgery"},{"issue":"2\u20133","key":"10.1016\/j.dld.2025.11.025_bib0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s003830000494","article-title":"Are stable postoperative biliary atresia patients really stable?","volume":"17","author":"Kobayashi","year":"2001","journal-title":"Pediatr Surg Int"},{"issue":"2","key":"10.1016\/j.dld.2025.11.025_bib0106","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00383-008-2311-9","article-title":"Immunological investigation of the hepatic tissue from infants with biliary atresia","volume":"25","author":"Baba","year":"2009","journal-title":"Pediatr Surg Int"},{"issue":"7","key":"10.1016\/j.dld.2025.11.025_bib0107","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/modpathol.3800374","article-title":"Matrilysin (MMP-7) is a major matrix metalloproteinase upregulated in biliary atresia-associated liver fibrosis","volume":"18","author":"Huang","year":"2005","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0108","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/cjp2.50","article-title":"Increased MMP-7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia","volume":"2","author":"Kerola","year":"2016","journal-title":"J Pathol Clin Res"},{"key":"10.1016\/j.dld.2025.11.025_bib0109","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jpeds.2018.12.006","article-title":"Quantification of serum matrix metallopeptide 7 levels may assist in the diagnosis and predict the outcome for patients with biliary atresia","volume":"208","author":"Wu","year":"2019","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2025.11.025_bib0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jpeds.2019.01.026","article-title":"MMP-7: the next best serum biomarker for biliary atresia?","volume":"208","author":"Harpavat","year":"2019","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.dld.2025.11.025_bib0111","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/hep4.1878","article-title":"Serum proteomics uncovers biomarkers of clinical portal hypertension in children with biliary atresia","volume":"6","author":"Osborn","year":"2022","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0112","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-230X-11-16","article-title":"Serum adiponectin and transient elastography as non-invasive markers for postoperative biliary atresia","volume":"11","author":"Honsawek","year":"2011","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0113","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S1665-2681(19)31343-2","article-title":"Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables","volume":"12","author":"Eslam","year":"2013","journal-title":"Ann Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231701","article-title":"Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis","volume":"15","author":"Benz","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0115","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00383-010-2799-7","article-title":"Association of circulating osteopontin levels with clinical outcomes in postoperative biliary atresia","volume":"27","author":"Honsawek","year":"2011","journal-title":"Pediatr Surg Int"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0116","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/jpsu.2001.21622","article-title":"Serum hyaluronic acid as an early prognostic marker in biliary atresia","volume":"36","author":"Dhawan","year":"2001","journal-title":"J Pediatr Surg"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0117","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1203\/00006450-199510000-00016","article-title":"Prognostic value of serum hyaluronic acid and type I and III procollagen propeptides in extrahepatic biliary atresia","volume":"38","author":"Trivedi","year":"1995","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0118","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76875-9","article-title":"Decreased circulating clusterin reflects severe liver complications after hepatoportoenterostomy of biliary atresia","volume":"10","author":"Udomsinprasert","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.dld.2025.11.025_bib0119","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/jpsu.2001.25798","article-title":"Serum concentration of adhesion molecules in postoperative biliary atresia patients: relationship to disease activity and cirrhosis","volume":"36","author":"Kobayashi","year":"2001","journal-title":"J Pediatr Surg"},{"issue":"9","key":"10.1016\/j.dld.2025.11.025_bib0120","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.jpedsurg.2005.05.050","article-title":"Soluble adhesion molecule profiling in preoperative infants with biliary atresia","volume":"40","author":"Davenport","year":"2005","journal-title":"J Pediatr Surg"},{"issue":"8","key":"10.1016\/j.dld.2025.11.025_bib0121","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00383-017-4116-1","article-title":"Elevated serum heat shock protein 70 and liver stiffness reflect hepatic dysfunction and severity in postoperative biliary atresia","volume":"33","author":"Honsawek","year":"2017","journal-title":"Pediatr Surg Int"},{"issue":"2","key":"10.1016\/j.dld.2025.11.025_bib0122","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0971-9261.176931","article-title":"Portal pressure and blood nitric oxide levels as predictors of outcome in biliary atresia","volume":"21","author":"Khanna","year":"2016","journal-title":"J Indian Assoc Pediatr Surg"},{"issue":"2","key":"10.1016\/j.dld.2025.11.025_bib0123","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/1354750X.2015.1045032","article-title":"Elevated serum periostin is associated with liver stiffness and clinical outcome in biliary atresia","volume":"20","author":"Honsawek","year":"2015","journal-title":"Biomarkers"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0124","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0022-3468(00)90211-2","article-title":"Elevation of serum interleukin-18 levels and activation of kupffer cells in biliary atresia","volume":"35","author":"Urushihara","year":"2000","journal-title":"J Pediatr Surg"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00383-012-3210-7","article-title":"Apelin is a marker of the progression of liver fibrosis and portal hypertension in patients with biliary atresia","volume":"29","author":"Chen","year":"2013","journal-title":"Pediatr Surg Int"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0126","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5009\/gnl14345","article-title":"Clinical implications of the serum apelin level on portal hypertension and prognosis of liver cirrhosis","volume":"10","author":"Lim","year":"2016","journal-title":"Gut Liver"},{"issue":"8","key":"10.1016\/j.dld.2025.11.025_bib0127","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025656","article-title":"von Willebrand factor as a biomarker of clinically significant portal hypertension and severe portal hypertension: a systematic review and meta-analysis","volume":"9","author":"Zou","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0128","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s43066-021-00159-8","article-title":"Role of plasma von Willebrand factor antigen in prediction of esophageal varices in pediatric and adolescent patients with portal hypertension","volume":"11","author":"El Shazli","year":"2021","journal-title":"Egypt Liver J"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0129","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-76040-6","article-title":"Elevated intestinal fatty acid-binding protein levels as a marker of portal hypertension and gastroesophageal varices in cirrhosis","volume":"14","author":"Miuma","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.dld.2025.11.025_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111356","article-title":"Elevated serum IL-34 is correlated with disease severity in patients with biliary atresia following Kasai portoenterostomy","volume":"127","author":"Honsawek","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"10.1016\/j.dld.2025.11.025_bib0131","article-title":"Transient elastography and von Willebrand factor as predictors of portal hypertension and decompensation in children","volume":"5","author":"Goel","year":"2023","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0132","first-page":"888","article-title":"Serum concentration of taurochenodeoxycholic acid predicts clinically significant portal hypertension","volume":"43","author":"\u017d\u00ed\u017ealov\u00e1","year":"2023","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0133","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1186\/s12876-022-02546-w","article-title":"Correlation between serum liver fibrosis markers and early gastroesophageal varices among patients with compensated liver cirrhosis: a cross-sectional analysis","volume":"22","author":"Mei","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"10.1016\/j.dld.2025.11.025_bib0134","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2468-1253(23)00438-7","article-title":"Pathophysiology and therapeutic options for cirrhotic portal hypertension","volume":"9","author":"Guix\u00e9-Muntet","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/hep.510280308","article-title":"Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats","volume":"28","author":"Sogni","year":"1998","journal-title":"Hepatol Baltim Md"},{"issue":"4","key":"10.1016\/j.dld.2025.11.025_bib0136","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/gut.50.4.571","article-title":"Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension","volume":"50","author":"Reynaert","year":"2002","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.dld.2025.11.025_bib0137","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13063-020-4203-9","article-title":"A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP)","volume":"21","author":"Gifford","year":"2020","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.dld.2025.11.025_bib0138","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1665-2681(19)32169-6","article-title":"Drug treatment for portal hypertension","volume":"1","author":"Mela","year":"2002","journal-title":"Ann Hepatol"},{"issue":"40","key":"10.1016\/j.dld.2025.11.025_bib0139","doi-asserted-by":"crossref","first-page":"6111","DOI":"10.3748\/wjg.v26.i40.6111","article-title":"Cirrhotic portal hypertension: from pathophysiology to novel therapeutics","volume":"26","author":"Gunarathne","year":"2020","journal-title":"World J Gastroenterol"},{"issue":"16","key":"10.1016\/j.dld.2025.11.025_bib0140","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1177\/1535370220949148","article-title":"Endothelin-1 in portal hypertension: the intricate role of hepatic stellate cells","volume":"245","author":"Ezhilarasan","year":"2020","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.dld.2025.11.025_bib0141","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107626","article-title":"Novel therapeutics for portal hypertension and fibrosis in chronic liver disease","volume":"215","author":"Guix\u00e9-Muntet","year":"2020","journal-title":"Pharmacol Ther"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825012241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825012241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:33:24Z","timestamp":1769085204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865825012241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":141,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1590865825012241"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2025.11.025","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The immunological profile of children with portal hypertension","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2025.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}